NDNF

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, NDNF mutation is significantly associated with the drug of many other genes, with 19 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible NDNF-associated genes across cancer lineages are Niraparib, LCL161, and 123829. Each is linked with NDNF in more than 1 cancer types. Because this analysis shows association rather than direction, both NDNF-to-partner and partner-to-NDNF results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Niraparib grouped by NDNF-low versus NDNF-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NDNF→partner) and Y-score (partner→NDNF) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINENiraparib →+0.358+2.646.045.04731
LARGE_INTESTINELCL161 →+0.430+2.646.007.04731
LARGE_INTESTINE123829 →+0.647+2.649.025.04631
LARGE_INTESTINEKRAS (G12C) Inhibitor-12 →+0.574+2.646.021.04731
LARGE_INTESTINEQuizartinib →+0.368+2.652.022.04531
LARGE_INTESTINEIAP_5620 →+0.368+2.649.046.04611
Each partner links to its Q-omics profile. Showing the 6 strongest of 19 associations by consensus.

Niraparib by NDNF expression — LARGE_INTESTINE

Box plot of Niraparib in NDNF-low vs NDNF-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration